Skip to main menu Skip to main content Skip to footer
Clinical Trial Aimed At Preventing Wet AMD Approved By FDA Starts Enrollment At SCDRC
Clinical Trial Aimed At Preventing Wet AMD Approved By FDA Starts Enrollment At SCDRC
Posted on: July 29, 2014
This is a multicenter, prospectively randomized, masked and controlled, interventional investigator sponsored phase I/II study of subjects with high-risk nonexudative age-related macular degeneration (AMD) treated with intravitreal ranibizumab quarterly for prophylaxis of conversion to exudative age-related macular degeneration. The objective of this study is to investigate the safety and efficacy of prophylactic anti-vascular endothelial growth […]
Read More
